ALSO NOTED: FDA faces harsh criticism; Will statins be targeted genetically?; and much more...

> The FDA's leadership faced withering criticism yesterday, as experts told a Congressional committee that the agency was underfunded, understaffed, overburdened, and seriously behind the times. Report

> If new research bears out, statins may soon be targeted at patients with a specific genetic variations. Report

> A new study suggests that healthcare CIOs and technology vendors don't understand each others needs very well--and that vendors may be making some very wrong assumptions. FierceHealthIT

> As if questions about the effectiveness of cholesterol meds weren't enough, now research is casting blood pressure remedies into doubt. Report

And Finally... Could this vaccine actually cure drug addiction? Article